Sensitivity of hepatitis C virus core antigen and antibody combination assays in a global panel of window period samples

BACKGROUND: Hepatitis C virus (HCV) antigen and antibody combination assays have been launched as a cost-effective alternative to nucleic acid testing (NAT) for reducing the antibody-negative window period (WP). Later, a HCV antigen chemiluminescence immunoassay (CLIA) became available. STUDY DESIGN...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Transfusion
Auteurs principaux: Laperche, Syria, Nubling, C. Micha, Stramer, Susan L., Brojer, Ewa, Grabarczyk, Piotr, Yoshizawa, Hiroshi, Kalibatas, Vytenis, El Elkyabi, Magdy, Moftah, Faten, Girault, Annie, van Drimmelen, Harry, Busch, Michael P., Lelie, Nico
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4744653/
https://ncbi.nlm.nih.gov/pubmed/26013970
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.13179
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires